Delivery Order SPE2DB22D1200-SPE2DB24FN4RT

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,497.81 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of June 10, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $29,480.21 and is a firm fixed price contract with a completion date of September 19, 2024. The contract is not set aside for any specific socioeconomic program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,757.17 firm fixed-price delivery order is for the supply of 4560471264 Eliquis 5 mg tablets. The contract has an ultimate completion date of April 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The order is valued at $10,145.24 and has an ultimate completion date of August 27, 2024. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Eliquis 5 mg tablets. The contract has a ceiling value of $23,179.78 and runs through June 27, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $8,008.10 and a completion date of October 24, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $5,777.75 and an ultimate completion date of September 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The $23,356.64 firm-fixed-price contract has an ultimate completion date of October 28, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,894.09, is for the supply of Eliquis 5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $28,039.44 and a period of performance through August 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN4RT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablet 60 count. The award is valued at $38,289.41 and has a completion date of September 10, 2024. The contract is a firm-fixed-price type, with no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The company has also been awarded a separate IDC by the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable government agencies to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/9/24, 2:04 PM